Nexgel logo

Nexgel(NASDAQ) NXGLW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-99%
5 YearN/A
1 Year-98%
1 Month-42%
$0.01
-15.56%
-0.00Today
Nexgel last closing stock price
MetricPriceDate
Last closeUSD 0.012026-10-23
Nexgel stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-23.23%USD 0.012026-10-16
1 month-41.54%USD 0.012026-09-23
3 month-73.33%USD 0.032026-07-24
Year to date-96.77%USD 0.242025-12-31
1 year-97.63%USD 0.322025-10-22
3 year-97.22%USD 0.272023-10-24
Since inception-99.03%USD 0.782021-12-22

Nexgel Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$12.07M

Net Income (TTM)

-$6.19M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.01

Volume

8,081

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.33

Estimated Earnings Date

Nov 17, 2026

NXGLW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nexgel

NEXGEL, Inc. specializes in the manufacturing of advanced hydrogels and gels, known for their high water content and unique properties. The company serves various sectors, including wound care, medical diagnostics, and cosmetic applications.

Products and Services
  • Specialized hydrogels for wound care and medical diagnostics
  • Cosmetic products like facial masks and under-eye patches
  • Transdermal drug delivery systems and foot care solutions
Growth Outlook
  • Revenue increased to $3.686 million in Q2 2026, up from $2.650 million in Q1 2026
  • Gross profit margin improved to 30.09% in Q2 2026 from 40.04% in Q1 2026
  • Strong demand for innovative products positions the company for future growth
Financial Highlights
  • Net income for Q2 2026 was -$3.635 million, reflecting ongoing investment in growth
  • Cash and cash equivalents stood at $492,000 as of June 30, 2026
  • Operating expenses totaled $3.614 million in Q2 2026, indicating strategic spending
NEXGEL, Inc. has established itself as a key player in the healthcare sector, focusing on innovative hydrogel technology. The company's diverse product offerings cater to a wide range of applications, enhancing its market presence. Recent financial performance indicates a positive trajectory, with revenue growth and improved gross profit margins. Despite challenges reflected in net income, the strategic investments in product development and marketing are expected to drive future growth. The company's commitment to innovation and quality positions it well for potential expansion in the healthcare market.
AI Generated • Oct 24, 2026

Industry

Healthcare Equipment and Supplies

Headquarters

Langhorne, PA 19047, US

NXGLW Financials

Key Financial Metrics (TTM)

Gross Margin

35.07%

Operating Margin

-44.77%

Net Income Margin

-51.26%

Return on Equity

-133.10%

Return on Capital

-44.41%

Return on Assets

-23.39%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

8.08K

Avg. Volume

12.44K

Financials (TTM)

Gross Profit

$4.23M

Operating Income

-$5.40M

EBITDA

-$2.11M

Operating Cash Flow

-$3.21M

Capital Expenditure

-$65.00K

Free Cash Flow

-$3.27M

Cash & ST Invst.

$492.00K

Total Debt

$7.46M

Nexgel Performance Analysis

Nexgel sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.7%
Q42025-12-31-4.7%
Q12026-03-31-5.2%
Q22026-06-3039.1%
Nexgel sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.9%
Q42025-12-31-50.0%
Q12026-03-318.3%
Q22026-06-30-263.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.69M

+27.8%

Gross Profit

$1.11M

-11.8%

Gross Margin

30.09%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

19

N/A

Net Income

-$3.64M

-446.6%

EBITDA

-$398.00K

+23.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$492.00K

-32.1%

Total Debt

$7.46M

+180.9%

Accounts Receivable

$1.08M

+43.3%

Inventory

$2.30M

+26.5%

Long Term Debt

$6.54M

+189.4%

Short Term Debt

$917.00K

+132.2%

Return on Assets

-23.39%

N/A

Return on Invested Capital

-44.99%

N/A

Free Cash Flow

-$2.27M

-432.3%

Operating Cash Flow

-$2.20M

-439.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FEMYFemasys Inc.
$1.50-3.85%
HBIOHarvard Bioscience, Inc.
$8.23-1.32%
CASICASI Pharmaceuticals, Inc.
$0.15+3.08%
SNYRSynergy CHC Corp.
$0.09+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$147.49+1.89%
TAT&T
$20.93-7.96%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%
NUNu Holdings
$15.16+2.92%

Questions About NXGLW

What is the current price of Nexgel?

Nexgel is trading at $0.01 per share.

What is the 52-week range for Nexgel?

Over the past 52 weeks, Nexgel has traded between $0.01 and $0.33.

How much debt does Nexgel have?

Nexgel total debt is unavailable.

How much cash does Nexgel have on hand?

Nexgel does not have cash on hand data available.

What is Nexgel’s dividend yield?

Nexgel does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.